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Abstract
Background: There is evidence to suggest that frontline community health workers in Malawi are under-referring
children to higher-level facilities. Integrating a digitized version of paper-based methods of Community Case
Management (CCM) could strengthen delivery, increasing urgent referral rates and preventing unnecessary re-
consultations and hospital admissions. This trial aims to evaluate the added value of the Supporting LIFE electronic
Community Case Management Application (SL eCCM App) compared to paper-based CCM on urgent referral, re-
consultation and hospitalization rates, in two districts in Northern Malawi.
Methods/design: This is a pragmatic, stepped-wedge cluster-randomized trial assessing the added value of the SL
eCCM App on urgent referral, re-consultation and hospitalization rates of children aged 2 months and older to up
to 5 years, within 7 days of the index visit. One hundred and two health surveillance assistants (HSAs) were stratified
into six clusters based on geographical location, and clusters randomized to the timing of crossover to the intervention
using simple, computer-generated randomization. Training workshops were conducted prior to the control (paper-CCM)
and intervention (paper-CCM + SL eCCM App) in assigned clusters. Neither participants nor study personnel were
blinded to allocation. Outcome measures were determined by abstraction of clinical data from patient records
2 weeks after recruitment. A nested qualitative study explored perceptions of adherence to urgent referral
recommendations and a cost evaluation determined the financial and time-related costs to caregivers of subsequent
health care utilization. The trial was conducted between July 2016 and February 2017.
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Discussion: This is the first large-scale trial evaluating the value of adding a mobile application of CCM to the assessment
of children aged under 5 years. The trial will generate evidence on the potential use of mobile health for CCM in Malawi,
and more widely in other low- and middle-income countries.
Trial registration: ClinicalTrials.gov, ID: NCT02763345. Registered on 3 May 2016.
Keywords: Integrated management for childhood illness (IMCI), Community health workers, Child health, Infectious
diseases, mHealth, Malawi
Background
Community Case Management (CCM) is a derivative of
the paper-based Integrated Management for Childhood
Illness (IMCI) clinical algorithm. The strategy was devel-
oped by the World Health Organization (WHO) and
United Nations Children’s Fund (UNICEF) to reduce the
burden of morbidity and mortality from leading causes
of disease (i.e., pneumonia, malaria and diarrhea) among
children aged under 5 years in low- and middle-income
countries (LMICs) [1–3]. CCM is a widely used inter-
vention for children aged under 5 years and is deployed
at village clinics by the largest cadre of community
health workers (CHWs) in Malawi, known as health sur-
veillance assistants (HSAs) [4].
Using a stepwise approach, CHWs are guided through
a “Sick Child Form,” constituting a series of standardized
questions and assessment items to direct clinical man-
agement [5]. Depending on the manifestation of “sick”
and “danger” signs, which are recorded by hand in a vil-
lage clinic register, children are given medicine or man-
aged at home. Those children who are severely unwell
and outside the scope of CHWs’ practice [6] are urgently
referred to the nearest higher-level health facility for
more comprehensive clinical management (which can be
primary- or secondary-care facilities including health
centers, community/rural or district hospitals), with ad-
vice given to caregivers about the reason for the referral
and the location of the nearest facility [7].
Correct identification of children requiring urgent re-
ferral is largely dependent upon CHWs’ fidelity to CCM
guidelines, which has been frequently reported as sub-
optimal [3, 7–10]. Poor completion of relevant CCM as-
sessment items may hinder early recognition of serious
illness, reducing urgent referrals to higher-level facilities.
Information about CCM-directed urgent referral rates in
Malawi is limited. However, assessment of the quality of
implementation of the CCM program after national
scale-up in 2008 reported that CHWs on average made
two urgent referrals (per 1000 children) each month [11].
Given the countries’ annual childhood mortality rates
from pneumonia (23%), malaria (14%) and diarrhea (18%)
[12], this suggests that many children meeting the classifi-
cation for urgent referral are not being identified. Under-
referral risks repeat consultations [13] for the same ill-
ness episode as well as hospitalization of those children
with serious illness who are left untreated. But, due to
the lack of an integrated and electronic medical record
system [14, 15], it is unclear which children are brought
back to village clinics because they are still unwell, and
which of those admitted to hospital were urgently re-
ferred by CHWs at the index visit.
Of equal importance is that children who are urgently
referred are actually taken to higher-level facilities (in
other words, that the referral is completed) when advised
[16, 17]. Failure to follow recommendations risks the
development of chronic conditions or acute complications
[18]. It is suggested that over 50% of caregivers in sub-
Saharan Africa whose children are urgently referred, do
not take their child for onward care [16, 19–21]. Prohibi-
tive financial and time-related costs incurred by caregivers
travelling large geographical distances to facilities [22],
and mistrust in CHW “diagnoses” and treatment decisions
[23, 24] have been cited as factors contributing to poor re-
ferral completion rates.
Utilizing mobile health (mHealth) technologies (e.g.,
smartphones, tablets) to deliver CCM could encourage
the dispensation of more appropriate treatment recom-
mendations [25] thereby increasing urgent referral rates.
Potential improvements may be underpinned by a com-
bination of better control of how the end-user navigates
through assessment questions (e.g., built-in validation
rules forcing completion of relevant fields with valid data
before advancing to the next field/screen) [26]; enhanced
CHW motivation linked to the prestige of using ad-
vanced technology in a predominantly paper-based health
care system; automated presentation of the next-steps re-
ducing reliance on memory [27], and heightened per-
ceived efficacy and caregiver trust in CHWs’ decisions
linked to clearer explanations about the child’s condition
and recommended treatment [27].
Despite the opportunities that mHealth may afford for
circumventing some of the limitations of current paper-
based delivery [26], there is a paucity of evidence demon-
strating the comparative benefits of deploying digitized
versions of CCM on health service utilization and asso-
ciated patient costs. To address this evidence gap in a
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pragmatic cluster-randomized trial, we will evaluate the
added value of an electronic CCM App (truncated to SL
eCCM App) developed as part of the Supporting Low-
cost Interventions For disEase control (Supporting LIFE)
program. As well as contributing to the broader mHealth
literature, we anticipate that trial findings will provide
Malawi’s mHealth Working Group with empirical data,
which can be used to inform policy regarding the oppor-
tunities to Malawi of introducing such interventions for
CCM. Our hypothesis is that adding the SL eCCM App to
sick child assessments will increase urgent referral rates
and reduce re-consultation and hospitalization rates.
The main objectives of this trial were to determine the:
▪ Added value of the SL eCCM App (used with paper-
CCM) on referral, re-consultations and hospitalization
rates among acutely unwell children aged under 5 years,
compared with paper-CCM alone
▪ Factors influencing caregivers’ decisions to comply
with urgent referral recommendations
▪ Direct and indirect costs to caregivers presenting to
higher-level facilities and/or re-attending village clinics
after the index visit when using paper-CCM and the
paper-CCM + SL eCCM App
Previous work justifying this trial
To address repeated calls for bridging the evidence gap
regarding mHealth interventions in LMICs [28–30], the
Supporting LIFE study team, which consisted of health
information systems (HIS) researchers, physicians, epide-
miologists and clinical researchers from Imperial College
London (ICL), University College Cork (UCC), University
of Washington (USA), Lund Universitet (Sweden), Mzuzu
University, Luke International (LIN) and the College of
Medicine (Malawi), purposely developed the SL eCCM
App [31]. Despite CCM being one of the most ubiquitous
child health interventions available in LMICs, there have
been few attempts to evaluate digitized versions of these
guidelines beyond pilot and feasibility studies. Given the
variable standards with which CCM is delivered by
CHWs, there is a need to identify alternative solutions to
enhance quality of health care delivery in the community.
The Supporting LIFE study team conducted a feasibil-
ity study between July and September 2015 which ex-
plored the acceptability and usability of the SL eCCM
App among HSAs in Malawi and the study procedures
proposed as part of this trial (the feasibility study, in-
cluding findings are described in [15] or are forthcoming
elsewhere). This trial builds on this previous work.
Methods/design
Trial design
This is a pragmatic, stepped-wedge cluster-randomized
trial assessing the added value of the SL eCCM App
(used with paper-CCM) on referral, re-consultation and
hospitalization rates of children aged under 5 years,
within 7 days of the index visit. This design was chosen
due to insufficient human resources to deliver the inter-
vention to all clusters simultaneously [32] and local ad-
vice that withholding the intervention to some clusters
may negatively affect participation. We aimed to recruit
102 HSAs and collect data on 8000 children from village
clinics across two districts in Northern Malawi between
July 2016 and February 2017. HSAs were grouped into
six geographic-based clusters. Training workshops were
conducted prior to the control (paper-CCM) and inter-
vention (paper-CCM + SL eCCM App) in assigned clus-
ters. Clusters were randomly assigned to the timing of
crossover from the control to the intervention [32] for
covariate equipoise between phases [33]. A nested quali-
tative study explored HSA and caregiver perceptions of
caregiver adherence to urgent referral recommendations;
a cost evaluation investigated the financial and time-
related costs to caregivers of seeking subsequent health
care for their child after the index visit. Figure 1 shows
the trial flow chart; Fig. 2 the trial design (before
randomization) and Fig. 3 the Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT)
Figure. This protocol adheres to the SPIRIT 2013 State-
ment for clinical trial protocols (Additional file 1) [34].
Methods
Study setting
Malawi is a land-locked country in central southern sub-
Saharan Africa [35]. It is one of the poorest nations in
the world, ranked 160th out of 182 on the Human De-
velopment Index [36]. Although 68% of health care ser-
vices are government subsidized [18], physical access is
limited and inequitable, with only 54% population resid-
ing within 5 km of the nearest health facility [37]. Al-
though English has been the official language of Malawi
since Independence in 1964 the majority of the popula-
tion have limited proficiency. Chichewa is the language
spoken in Nkhata Bay and Tonga and Tumbuka are
spoken in Rumphi District; all of which were provisioned
for in this trial. HSAs are posted to hard-to-reach loca-
tions where they deliver a mixture of preventative and
curative community health programs to a catchment
area of approximately 1000 people [4]. They receive
6 days of initial CCM training [5, 6, 11] before imple-
menting CCM to children aged under 5 years from village
clinics (operated by one HSA). Village clinics are equipped
with rudimentary job aids, which typically include the
paper-CCM decision pro forma in English (referred to as
the Sick Child Form), a village clinic register for recording
patient visits [5], a stopwatch for measuring respiratory
rate (RR), and access to basic medications.
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Fig. 1 Trial flow diagram
Fig. 2 Trial design
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Eligibility criteria
Inclusion criteria
Participants were eligible to be included in the trial if
they fulfilled the following criteria:
Health surveillance assistants
▪ Completion of the Ministry of Health’s (MoH’s) 6-day
CCM training program
▪ Fluent in spoken and written Chichewa, Tonga or
Tumbuka (± English)
▪ Attendance at both training workshops
▪ Voluntary written consent
Caregivers
▪ Caregivers are aged 18 years and older
▪ Caregivers with spoken fluency in Chichewa, Tonga
or Tumbuka (it is not anticipated that many will speak
English)
▪ Child is aged 2 months or older and up to 5 years
▪ Voluntary verbal consent
Exclusion criteria
Participants fulfilling any of the following criteria were
not eligible to take part in this trial:
Health surveillance assistants
▪ Unable/unwilling to attend both training workshops
▪ Unable/decline voluntary written consent
Caregivers
▪ Caregiver is aged below 18 years
▪ Child is aged below 2 months or 5 years and older
▪ Child is convulsing, unconscious or unresponsive at
presentation
▪ Unable/unwilling to give voluntary verbal consent
The Supporting LIFE electronic Community Case
Management Application
SL eCCM App is a smartphone App developed for An-
droid OS 3.0 Honeycomb or above; the smartphone se-
lected to run the App for this trial was the HTC Desire
526G. The App is in English and replicates the paper-
based CCM decision aid (i.e., the Sick Child Form) in
terms of wording and order of presentation of assess-
ment questions (Fig. 4). Patient data is entered via a
touch-sensitive dynamic interface. Field validation forced
HSAs to complete all required fields prompted by the
App’s decision rule and within clinically valid parame-
ters. Current configuration of the SL eCCM App only
permits data entry and so previously entered records
cannot be retrieved. Included in the App is a countdown
tap-screen feature for measuring RR. The number of
screen taps within 60 s equates to a child’s RR. Whilst
60 s was the default measurement period for the trial,
the App permits the user to select shorter periods (i.e.,
15, 30 and 45 s), where a RR equivalent of 60 s is calcu-
lated from the time intervals between taps. HSAs were
encouraged to use this feature, but could elect to use the
stopwatch (as per standard practice). The SL eCCM App
Fig. 3 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Figure
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uses RESTful web services communicating over JSON to a
Cloud-based web server, running on an Amazon Elastic
Compute Tomcat instance. The web-server comprises a
middle-tier Spring Model-View Controller framework and
uses Java Persistence API to communicate to a back-end
MySQL database running on an Amazon Relation Data-
base Service instance. My SQL database (referred to as the
SL central database) is supported by Amazon Web Ser-
vices (AWS) Cloud data storage solutions, and has been
created to store uploaded patient data from the SL eCCM
App (Fig. 5). Patient data is uploaded onto the SL central
database when the App is physically synced with the cen-
tral database. The robustness and fidelity of the App’s clin-
ical algorithm to paper-CCM was tested iteratively over
the 4 years of development against a suite of automated
tests. It also underwent additional manual checks by
members of the study team (which includes a family phys-
ician), by creating artificial clinical scenarios and cross-
referencing the logic with the Sick Child Form), as well as
with 12 HSAs in a feasibility study conducted in Malawi
between July and September 2015 [15].
Outcome measures
Main outcomes
▪ Urgent referrals to higher-level facilities in the 7 days
following the index visit, ascertained from abstraction
of patient records 2 weeks after the index visit.*
◦ Caregiver-completed referrals in the 7 days following
the index visit, determined from abstraction of patient
records (i.e., caregivers who were urgently referred
and who presented)
◦ Caregiver self-referrals to primary or secondary
health facilities (i.e., parents/caregivers of children
not urgently referred at the index visit, but who
presented anyway)
▪ Re-consultations at village clinics due to deterioration
of illness, and hospitalizations in the 7 days following
the index visit ascertained from abstraction of patient
records 2 weeks after the index visit
*Primary outcome measure used to determine the num-
ber of participants needed to power the trial.
Fig. 4 Screenshots of the Supporting LIFE electronic Community Case Management Application (SL eCCM App)
Fig. 5 System architecture supporting the Supporting LIFE electronic Community Case Management Application (SL eCCM App)
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Other outcomes
▪ HSA and caregiver-perceived barriers and facilitators
to caregiver compliance with urgent referral
recommendations
▪ Direct and indirect costs to caregivers of planned and
unplanned re-consultations and urgent referrals to any
type of health facility (i.e., health centers, community/
rural and district hospitals)
▪ HSA and caregiver attitudes towards the SL eCCM
App and the intervention experience
Recruitment
Recruitment was coordinated from Luke International Of-
fices in Mzuzu, Mzimba North District. HSAs were identi-
fied from village clinics listed on the Demographic and
Health Information System 2 (DHIS 2 http://www.dhi-
s2.org/) database (a repository for centralizing health data)
that is used widely across Africa [38]. Guidance was
sought from district-level Ministry of Health (MoH) offi-
cials (e.g., District Health Officer, District Environmental
Health Officer, IMCI coordinator) in Rumphi and Nkhata
Bay to identify the status of listed village clinics (i.e.,
whether an HSA is in situ) and how to approach/access
HSAs. A reserve of HSAs was identified in case any identi-
fied village clinics are inactive, or HSAs do not wish to
participate. HSAs were to be invited to participate by the
local study team, either in person or over the telephone.
Caregivers and their children were identified and enrolled
consecutively by HSAs as they presented to village clinics.
Based on average HSA recruitment rates during the feasi-
bility study of 10 children per HSA each week, we antici-
pated that 8000 children would be enrolled into the trial.
Assignment of interventions
Randomization, allocation and blinding
HSAs were stratified by geography into six clusters by the
local study team and each cluster was given a num-
ber between 1 and 6 Using computer-generated simple
randomization techniques, each of the six clusters was
randomized to the sequence and timing at which they
crossed over from the control to the intervention (Fig. 3)
[39]. Clusters were randomized once allocated to geo-
graphic clusters. Caregivers and their child were allocated
to the control or intervention by chance, depending on
the time that they presented to village clinics. Due to the
nature of the intervention, neither trial participants nor
the trial team were able to be blinded to assignments.
Trial procedures
Training workshops
HSAs attended two 1-day training workshops where
they learnt how to use the SL eCCM App and became
familiarized with study procedures with other HSAs in
the same cluster. At the first training workshop HSAs
were taught how to operate the smartphone (e.g., turn-
ing device on/off; navigation to the SL eCCM App); use
the SL eCCM App (e.g., navigate through clinical ques-
tions and assessment items; were taught procedures for
uploading data onto the central database, using the em-
bedded breathing rate counter) and follow study proce-
dures (i.e., how to recruit and obtain verbal consent
from caregivers, and record data in the SL eCCM App
and paper-CCM in parallel). At the end of the first train-
ing workshop a mobile phone without the SL eCCM
App was issued to HSAs, allowing them to become fa-
miliar with the device. The App was removed from de-
vices at this time to prevent HSAs using it to treat
children during the control phase.
The second workshop was a “refresher” session, con-
ducted 1–2 weeks before each cluster crossed over to
the intervention (i.e., paper-CCM+ SL eCCM App). The
SL eCCM App was downloaded onto the mobile phones
assigned to HSAs, ready for the intervention phase. Ma-
terial covered in the first workshop was also revised. To
consolidate learning and encourage compliance with
study procedures, clinical vignettes were conducted to
simulate study procedures expected to be undertaken by
HSAs in the intervention phase.
To ensure a manageable ratio of trainers to HSAs, train-
ing workshops were limited to a maximum of 20 HSAs.
Training workshops were led by the study team in English,
and included a team member fluent in the primary lan-
guage spoken by participants who could facilitate commu-
nication. During the blocked-out time periods allocated to
training workshops, HSAs continued to use paper-CCM
as per standard practice, but were not able to enroll chil-
dren during this transitory stage (prevented by removing
all study materials from village clinics).
Data collection
Baseline
Control
Paper-CCM was used to assess and treat children for be-
tween 2 and 7 weeks (dependent on clusters’ assigned
sequence from randomization), as per standard practice.
Facilitated by the Sick Child Form, patient data routinely
collected by HSAs through a series of questions and
physical examinations was recorded in the village clinic
register and included: demographic data (i.e., child and
caregiver name, child date of birth, relationship of care-
giver to child, physical address); the presence and dur-
ation of “sick” signs (i.e., diarrhea for less than 14 days
without blood in stool, fever for less than 7 days, red eye
for less than 4 days, fast breathing) and “danger” signs
(i.e., cough for 21 days or more, diarrhea for 14 days or
more, blood in stool, fever lasting for 7 days, convulsions,
not able to feed or drink anything, vomits everything, red
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eye for 4 days or more, red eye with visual problem,
chest recession, very sleepy or unconscious, palmar pal-
lor, red/yellow on MUAC tape, swelling of both feet);
treatment decision (i.e., urgent referral or treat at home
and advise on homecare, including when to return for
follow-up) and medication dispensed (e.g., antibiotics,
oral rehydration therapy).
Intervention
After HSAs in each cluster completed their allocated time
in the control and the second training workshop, they
transitioned to using the SL eCCM App in addition to
paper-based CCM for between 2 and 7 weeks. The same
patient data recorded in the control was collected and re-
corded concurrently in the SL eCCM App and village
clinic register. Dual-use and double-data entry were ne-
cessary due to functional limitations of the SL eCCM App
and because completion of the village clinic register is
mandatory for monthly aggregation of cases for country-
level disease surveillance purposes. During technical mal-
functions (e.g., software bugs, power failures, etc.) that
prevented use of the App, or scenarios where caregivers
could not be consented, HSAs temporarily reverted to
paper-CCM only. HSAs dispensed treatment using rec-
ommendations prompted by the SL eCCM App, but could
elect to follow recommendations of paper-CCM where
they strongly disagreed with the App’s recommendations.
Use of the breath count feature to measure RR was en-
couraged, but HSAs could choose to use the stopwatch
(as per standard practice) if they preferred.
Follow-up
Two weeks following enrollment, caregivers recruited
in both the control and intervention phases were con-
tacted by the study team via the mobile telephone num-
ber (provided at recruitment), or in person (if they did not
provide a number, or were unreachable on the number
provided). They were asked by one of the Malawian study
team for details of: treatment recommendation given by
HSAs at the index visit; re-attendances at village clinics,
presentations to higher-level facilities and hospitaliza-
tions of their child in the 7 days following the index
visit. Since identification of patient records at sites is
anticipated to be cumbersome due to poor medical ad-
ministrative infrastructure [15, 40], information pro-
vided by caregivers was used to direct the study team
to sites where a record of the patient visit was most
likely to be available. Caregiver-reported data will be
cross-referenced with data abstracted from patient re-
cords to determine the trustworthiness of gathering
data from village clinics and higher-level health
facilities.
The study team systematically visited participating vil-
lage clinics and higher-level health facilities within the
catchment area of recruiting village clinics to retrospect-
ively obtain the following from patient records: HSAs’
treatment decisions and scheduled follow-up visits with
caregivers at the index visit (i.e., urgent referral, treated
at home/advice to caregiver); dates of re-attendances at
village clinics (including signs/symptoms at presentation
and medications administered, if any); dates of atten-
dances and hospitalizations (including diagnoses and
medication administered, if any). Follow-up data was re-
corded on a Case Report Form (CRF).
A subgroup of caregivers, recruited in both the control
and intervention phases, who returned to village clinics
or who took their child to a higher-level health facility
(irrespective of whether an “urgent referral” recommen-
dation was given at the index visit), were asked to
complete a Patient Costs Questionnaire (PCQ). The sur-
vey was adapted from the Cooking and Pneumonia
Study (CAPS) implemented in Malawi [41] and collected
sociodemographic details (e.g., level of education, marital
status, occupation), financial (e.g., cost of transportation,
medication) and time-related (e.g., duration of travel)
costs associated with seeking subequent health care for
their child. Where practical, survey data was collected
from caregivers over the telephone, or, obtained in per-
son in the community with the assistance of the recruit-
ing HSA. Because we anticipated mixed literacy levels
among the patient population, the survey was completed
either by the caregiver, or by a member of the study
team fluent in the local language, who read the ques-
tions and scribed on behalf of caregivers. A convenience
sample of enrolled HSAs and caregivers from each clus-
ter participated in a semi-structured interview 1–2
weeks after the intervention (HSAs) or recruitment
(caregivers), respectively. One-to-one interviews were
conducted in person (or depending on location/availabil-
ity of caregivers, over the telephone) by a member of the
study team fluent in the primary language of partici-
pants. This interview format was selected due to the in-
fluence that cultural factors (e.g., collectivism, gender
and sociodemographic inequities) could have on open-
ness of communication in group interviews [42]. Tai-
lored, semi-structured topic guides were used to
facilitate interviews and included questions relating to
perceptions of the barriers and facilitators to caregiver
compliance with urgent referral recommendations and
the perceived impact of the SL eCCM App. Topic guides
were developed by the study team and were informed by
nascent research related to challenges of accessing health
care in LMICs, and from findings from focus groups held
as part of the feasibility study. All interviews were audio-
recorded, lasted between 30 and 40 min, and were held in
private. Data collection instruments and/or interview
guides can be made available upon request to the corre-
sponding author.
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Sample size
We planned to recruit a total of 102 HSAs. Our sample
size estimation is based on change in proportions of the
primary outcomes expected pre and post intervention.
Assuming an alpha of 0.05, 97 HSAs would provide 80%
power for a minimum detectable rate of change between
6 and 7% in referral, re-consultation and hospitalizations
(one-sided test). We assumed a 1% urgent referral rate,
based on the proportion of children identified as needing
to be urgently referred at clinics in a previous study con-
ducted in Malawi [11]. As an urgent referral rate of 8%
has been estimated as a reasonable consensus referral
rate at clinics in sub-Saharan Africa [43, 44] that are cor-
rectly adhering to IMCI, we assumed the addition of the
SL eCCM App could improve urgent referral rates close
to this estimate; a 6–7% change between the control and
intervention was, therefore, a conservative estimate of
this assumption. Given the short trial duration and po-
tential of perceived elevated status through smartphone
ownership in this setting [45], we did not expect many
HSAs to drop out. We believed that recruiting 102
HSAs would be sufficient to accommodate potential
dropout, to ensure we achieved our desired sample size.
Power calculations were computed using the “Power and
Sample Size” option in Stata v. 13 (StataCorp, College
Station, TX, USA) [46] which is appropriate for rates,
specifically “longitudinal studies, where the same cases
serve as their own controls over time” [47].
A total of 300 parents/caregivers whose children were
referred to a higher-level facility or re-consulted at a vil-
lage clinic completed the PCQ. It was estimated that ap-
proximately 600 children would be eligible for referral to
a health care facility assuming: a 1% referral rate among
4000 children in the control group (n = 40), a 7–8% re-
ferral rate (change 6–7% from the initial 1% referral rate)
among the same number of children in the intervention
group (n = 300) and a 6–7% under-referral rate in the
control group (n = 260). Considering the challenges in
identifying those who were referred but did not present
at a health care facility, or those who were not referred
but did visit a health care facility or represented at a vil-
lage clinic, and the possible withdrawal or loss to follow-
up of parents/caregivers, it is estimated that at least half
(n = 300) of the eligible cases will be followed up as part
of the cost evaluation.
We also interviewed 15 HSAs and 25 caregivers to ex-
plore barriers and facilitators to caregiver compliance with
referral recommendations, as well as HSA and caregiver
acceptability of the SL eCCM App. Pre-determining the
number of participants needed in qualitative research is
challenging since the underlying goal of achieving satur-
ation is influenced by factors including interview type
(typically one-to-one interviews foster deeper but more
narrow exploration of concepts than focus groups, due to
absence of exchange of opinions which broaden scope),
homogeneity of interviewees, and skill of the researcher
(among other things). Guest et al. indicated 12 semi-
structured interviews as sufficient to attain saturation [48].
Since our approach is exploratory rather than theoretical,
we believed that our target sample size would be sufficient
to address our research question and accommodate any
heterogeneity among either participant population.
Data management
To give HSAs an organic user experience, identifiable
data was entered into the SL eCCM App. Once the rec-
ord was saved, patient-identifiable information entered
(i.e., child and parent name, physical address) was auto-
matically removed and date of birth was transposed into
age (in months). Patient data was held within the SL
eCCM App in SQLite database tables until the App was
synced with the SL central database, when patient re-
cords were automatically removed from the App. De-
identified patient data held in database tables within the
App was encrypted using secure, 256-bit AES SQLCi-
pher technology. HSAs synced the SL eCCM App with
the server from village clinics, or other community loca-
tions with a WIFI or data network. Patient records were
transmitted by HSAs daily, or as soon as they were able
to reach an area with connectivity. Secure Sockets Layer
(SSL) technology was used to protect data during trans-
mission from the SL eCCM App to the SL central data-
base, which was managed through a website created to
provide an infrastructure for administrative support dur-
ing the trial (e.g., creating HSA accounts). This website
was developed using Java Server Pages (JSP), Bootstrap,
JQuery, HTML 5.0 and CSS 3.0. SQLCipher is the tech-
nology adopted for provisioning data encryption. SQLCi-
pher is an open-source library that provides transparent,
secure, 256-bit AES encryption of SQLite database files.
SQLCipher has been adopted as a secure database solu-
tion by many commercial and open-source products,
making it one of the most popular encrypted database
platforms for mobile applications. The SL database is
hosted within the AWS data center in Ireland, which is
the European base for AWS service provision. User-
authentication controls restricted access to the SL eCCM
App and SL central database to authorized trial personnel.
The quality of data collection in this trial was contin-
gent upon the completeness and accuracy of patient re-
cords at village clinics and higher-level health facilities.
To ensure that all available data was abstracted from pa-
tient records at these sites, CRF and PCQ Forms were
reviewed for completeness by a member of the local
study team prior to data entry. De-identified CRF and
PCQ data was double entered into the Health Insurance
Portability and Accountability Act (HIPAA)-compliant
Research Electronic Data Capture (REDCap) system,
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which was managed by the local trial team in Malawi
and monitored remotely by the trial sponsor. REDCap
database was set up with double-data entry and valid-
ation rules to identify and manage data discrepancies.
Data entered into REDCap was reviewed continually
during the trial. Missing or inconsistent data was identi-
fied and data verification requests generated by the
sponsor institution to resolve discrepancies. Individual
characteristics of CHWs (e.g., education level) have been
associated with enhanced performance in resource-poor
settings [49]. Location of village clinics and higher-level
health facilities may also influence the quality of medical
reporting in patient records and thus the data that is
available to be abstracted for this study. HSAs operating
in more urban areas may have better access to training
and supervision. Urban regions with better infrastruc-
ture might have more standardized and organized
reporting systems, or conversely, less rigorous proce-
dures because of higher patient volumes. As the factors
driving missing data (in addition to attrition of HSAs) in
this study risk biasing observed data collected, we can-
not assume that data will be missing at random. There-
fore, missing data will not be imputed [50]. Upon trial
completion, the percentage of missing data between con-
trol and intervention phases will be compared. We will
use a logistic model to assess whether any covariates sig-
nificantly predict dropout rates; differential dropout will
be assessed. Non-outcome variables will be interpolated
to improve multivariate models if needed.
Confidentiality
Patient records entered into the SL eCCM App during
the intervention are identified using a unique, five-digit,
study ID number and HSAs are identified from a
unique, four-digit number (as pre-populated on com-
pleted consent documents). A link between participant
ID number and participant names (children and HSAs)
is stored in a separate electronic file and will be broken
as soon as it is practical to do so. Since a single HSA is
typically assigned to each village clinic in Malawi, dis-
closure of study sites would constitute the release of
identifiable data. Therefore, to protect participant’s iden-
tity, the list of included village clinics will not be made
available. Audio files of interviews will be uploaded and
transcriptions stored onto a password-protected com-
puter. Participant identifiers accidentally disclosed dur-
ing interviews will be removed during transcription and
replaced with generic terms (e.g., personal names will be
replaced with “a colleague” or “family member”). Partici-
pant quotes used in any material resulting from this trial
will be protected using their unique ID number. All ori-
ginal study documents (i.e., consent documents, CRFs,
PCQs) are stored securely at the local coordinating insti-
tution in Malawi (LIN) with access restricted to
authorized personnel. After trial closure these trial docu-
ments are to be archived locally for 6 years in accordance
with the University of Washington’s Human Subjects Div-
ision and COMREC’s requirements, and will only be made
available under exceptional circumstances (e.g., audit).
After verification of data accuracy, electronic datasets will
be locked and stored on encrypted institutional networks.
Post-trial care
After trial completion, children aged under 5 years pre-
senting to village clinics were to continue treating chil-
dren aged under 5 years according to standard practice
(paper-CCM only).
Statistical/analysis methods
Primary outcome data will be evaluated using pairwise
comparisons during the control and intervention pe-
riods. Analyses will be conducted at the level of the
HSA, taking into consideration the number of index
visits that occurred during each period, and will include
descriptive statistics relating to each outcome (i.e., refer-
ral, re-consultation and hospitalization rates); tests of
differences by control/intervention period, and multi-
variate modeling to allow for adjustment of potential
confounding factors within each period. Bivariate descrip-
tive statistics will present proportions for categorical vari-
ables or means/standard deviations for continuous and
categorical data (respectively), for control/intervention pe-
riods. Measures of change will be calculated and two-
proportion z-tests or chi-square tests will be used to
measure unadjusted differences (depending on test as-
sumptions met). We will conduct multivariate analysis
using linear regression to evaluate change in outcomes ad-
justed for composition of children at each HSA by age,
gender, symptoms, location (urban/rural) and proximity
to the nearest higher-level health facility. For these
models, assumptions will be tested, transformations of
variables will be made if needed, and a-priori confounders
will be evaluated for inclusion in models. Effect modifica-
tion will be tested by interactions with age and gender. A
secondary analysis will be done at the level of the child
adjusting for HSA as a cluster variable. Potential con-
founders and effect modifiers will also be tested in these
models. Data analysis and reporting will be conducted
with Consolidated Standards of Reporting Trials (CON-
SORT) [51].
A cost-consequence analysis will be conducted to re-
port the costs and consequences under the control and
intervention. All costs of seeking and receiving care for
the control and intervention groups will be calculated
separately in a disaggregated way at the household level.
Direct costs (e.g., out-of-pocket payments and transporta-
tion costs), indirect costs (e.g., costs of parent/caregiver
productivity loss) and consequences (e.g., hospitalization
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days) collected through the PCQ will be compared be-
tween parents/caregivers enrolled in the control and inter-
vention phases.
Audio-recordings from interviews will be transcribed
and translated into English during data collection. It is an-
ticipated that audio-recordings will take some time to be
translated and transcribed, making theoretical sampling
impractical. Therefore, data synthesis will commence as
soon as it is practical to do so. Appropriate qualitative
synthesis techniques will be employed, and reporting will
adhere to the consolidated Criteria for Reporting Qua-
litative research (COREQ) [52]. Qualitative data will be
triangulated with primary outcomes to contextualize
quantitative findings. Qualitative software package NVivo
10 will be used to organize the data.
Monitoring
Data Monitoring and Safety Committee (DMSC)
To protect the ongoing rights and safety of participants
and the scientific and ethical integrity of the trial, we
convened a DMSC. Members of the DMSC were inde-
pendent of the sponsoring institution and possessed the
jurisdiction to periodically review and provide guidance
on the handling of adverse events (AEs), protocol devia-
tions and accumulating trial data. Due to the short dur-
ation of the trial there were no plans to conduct interim
analyses. The DMSC may review and analyze cumulative
trial data as requested by its members, at any time dur-
ing or after the trial. The DMSC possessed the auton-
omy to recommend protocol modifications, corrective
actions, and suspension or termination of the trial if not
satisfied that standards of trial conduct were being met.
Harms
Adverse events and serious adverse event reporting
An adverse event (AE) is defined as “any untoward
medical occurrence in a trial participant which, having
been absent at baseline or if present at baseline, appears
to have worsened.” A serious adverse event (SAE) is
“any untoward and unexpected medical occurrence or
effect that: results in death; is life-threatening (refers to
an event during which the participant was at risk of
death at the time of event; it does not refer to an event
which hypothetically might have caused death had it
been more severe); requires hospitalization or pro-
longation of existing hospitalization, results in persist-
ent or significant disability/incapacity or is a congenital
anomaly or birth defect” [53].
AEs were monitored in the first instance by the local
trial team and were reported electronically and at bi-
weekly team meetings to the sponsor institution. The lead
researcher (MT, who is a family physician) and clinical
trial program manager (VH) assessed the nature of all re-
ported AEs for causality, expectedness and seriousness.
Additional data was requested by the sponsoring institu-
tion to determine whether an AE or SAE has occurred.
All events will be discussed and, where necessary, man-
agement advice sought from the DMSC. Where the inci-
dent was deemed to be both related and unexpected, the
sponsoring institution informed the Human Subject’s Div-
ision at the University of Washington and COMREC
within 24 h of receiving notification of the AE.
We expected some children presenting to village
clinics to be seriously ill, but we did not anticipate AEs
resulting from the use of the SL eCCM App, or from
study procedures. Multiple precautionary measures were
put in place to prioritize the welfare of participants and
maintain standards of health care. Specifically, the SL
eCCM App is used as an adjunct to standard care and
HSAs possess the autonomy to defer to paper-CCM in
the event of disagreement with treatment recommenda-
tions or technical issues preventing use. Additionally,
children perceived to have life-threateningly illness at
presentation were not eligible for enrollment, and the
use of the SL eCCM App could be aborted by HSAs at
any time and for any reason. The primary concern asso-
ciated with this trial was the additional workload that
double assessment and data entry would impose on
HSAs and the resultant increased time taken to assess
children, which could negatively impact compliance with
study procedures. The study team periodically tele-
phoned HSAs and conducted site visits to ensure proper
execution of study procedures and monitor HSAs’ contin-
ued willingness to participate. We simplified the processes
as much as is possible without compromising participant
safety or data quality. These study procedures were suc-
cessfully implemented in a previous feasibility study, with
no deviation from the procedures suspected or found.
Sponsorship and auditing
The University of Washington was the trial sponsor and
was responsible for overseeing all aspects related to the
management and conduct of the trial. Responsibilities
for trial activities were delegated to collaborating institu-
tions. The trial is open to inspection and audit by the
University of Washington as the sponsoring institution,
and the Malawi College of Medicine Research Ethics
Committee (COMREC), responsible for local oversight
of this trial.
Publication policy and dissemination
The full statistical analysis plan will be made publicly
available prior to statistical analysis. The final de-identified
dataset will be made available on a public repository. Re-
sults from this trial will be presented in aggregate and
published in peer-reviewed journals, and in accordance
with the Supporting LIFE publication policy. There are no
plans to use professional writers for any of the research
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output from this trial. The authors will declare on all man-
uscripts, websites, press releases and any other communi-
cations materials that the project has received funding
from the European Union’s Seventh Framework Program
for research, technological development and demonstra-
tion under grant agreement number 305292, in acknow-
ledgement of the trial funding body.
Discussion
To the authors’ knowledge the Supporting LIFE trial is
the first large-scale trial evaluating the added value of an
electronic version of CCM compared to paper-CCM
alone. This trial will provide important data regarding
the impact of digitizing CCM on HSA urgent referral
practices and factors influencing health service
utilization in Malawi. The outcome of referral rate pro-
vides a proxy quality indicator: higher urgent referral
rates and reduced re-consultation and hospitalization
rates compared to paper-CCM may suggest that inte-
grating digitized versions of CCM to the clinical workup
improves standards of CCM delivery. Our findings may
also be used by the mHealth Working Group in Malawi
and decision-makers in other LMICs to better determine
the benefit to health care of introducing similar mHealth
CCM tools. More broadly, this trial is expected to in-
form the design and conduct of future evaluations of
mHealth technologies for CCM.
Several obstacles influenced how this trial was designed.
Firstly, due to a mixture of financial, human resource and
time constraints, we were unable to incorporate some the
appendages of CCM into the SL eCCM App (i.e., vaccin-
ation record) as well as the capability to retrieve previous
records of patient visits to review. Secondly, it is a require-
ment of the Malawian MoH for a physical record of every
patient visit to be retained at village clinics. Without inte-
gration of the SL eCCM App with the local health infor-
mation systems, electronic data submission to the MoH
was not feasible. Therefore, evaluating the standalone im-
pact of the SL eCCM App was not possible, thus limiting
causality between intervention and outcome. Thirdly, the
lack of electronic and integrated medical records across
health facilities makes corroborating attendances at
higher-level health facilities cumbersome. Therefore, a 7-
day follow-up period was chosen to balance the follow-up
window against the workload and likelihood of being able
to locate patient records of at sites. Data of children in de-
veloped countries shows that symptoms for respiratory in-
fections can persist for up to 21 days, (mean duration
between 4 and 16 days) [54], meaning that some presenta-
tions related to the same illness episode may be missed.
Similarly, excluding the most severely ill children (i.e.,
those who are convulsing, unconscious/unresponsive at
presentation) may result in under-representation of
hospitalization rates. Because of the added time that trial
procedures were anticipated to impose on participants,
we wanted to ensure that prompt management of these
children was prioritized in scenarios where the child’s
condition could become rapidly life-threatening. We
believe that focusing on outcomes arising immediately
after baseline provides a better reflection of the quality
of CCM delivery at initial contact.
Trial status
This trial opened to recruitment on 24 October 2016
and collected follow-up data by 3 February 2017.
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